PDS Biotechnology Corp (FRA:EU6)
€ 2.814 0.028 (1.01%) Market Cap: 112.55 Mil Enterprise Value: 81.65 Mil PE Ratio: 0 PB Ratio: 3.92 GF Score: 37/100

Q2 2021 PDS Biotechnology Corp Earnings Call Transcript

Aug 12, 2021 / 12:00PM GMT
Release Date Price: €8.97 (-1.99%)
Operator

Greetings, and welcome to PDS Biotechnology's Second Quarter 2021 Financial Results. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Deanne Randolph, Vice President of Commercial Development. Please go ahead.

Deanne Randolph
PDS Biotechnology Corporation - VP of Commercial Development & Head of IR

Good morning, and welcome to PDS Biotechnology's second quarter 2021 earnings conference call and audio webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Dr. Seth Van Voorhees, Chief Financial Officer. Earlier this morning, PDS Biotech issued a press release announcing financial results for the quarter ended June 30, 2021. We encourage everyone to read the press release as well as PDS Biotech's quarterly report on Form 10-Q, which was filed with the SEC earlier this morning. The company's press release is available on PDS Biotech's website at pdsbiotech.com and the quarterly report will be posted later

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot